Mckesson Bismuth Tablet, Chewable
NDC Package 68599-4744-7

11-digit billing NDC: 68599474407

Package Information

Mckesson Bismuth (bismuth subsalicylate) tablets is usesrelievestraveler's diarrheadiarrheaupset stomach reliever due to overindulgence in food and drink, including: • heartburn • indigestion • nausea • gas • belching• fullness. This formulation utilizes a tablet, chewable delivery system. Marketed by Mckesson Medical-surgical, this product is identified by NDC 68599-4744 and is authorized under FDA application M008.

Identification & Billing

NDC Package Code
68599-4744-7
Package Description
100 PACKET in 1 BOX / 2 TABLET, CHEWABLE in 1 PACKET
Product Code
11-Digit Billing Format
68599474407
RxNorm Crosswalk
RxCUI: 308761 - bismuth subsalicylate 262 MG Chewable Tablet

Clinical Specifications

Proprietary Name
Mckesson Bismuth
Non-Proprietary Name
Bismuth Subsalicylate
Substance Name
Bismuth Subsalicylate
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Usesrelievestraveler's diarrheadiarrheaupset stomach reliever due to overindulgence in food and drink, including: • heartburn • indigestion • nausea • gas • belching• fullness

Regulatory & Marketing

Labeler Name
Mckesson Medical-surgical
Product Type
Human Otc Drug
FDA Application #
M008
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-01-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68599-4744-7 identifies a specific commercial package of 100 packet in 1 box / 2 tablet, chewable in 1 packet of Mckesson Bismuth, a human over the counter drug labeled by Mckesson Medical-surgical. This tablet, chewable is formulated for oral use and contains bismuth subsalicylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mckesson Medical-surgical on March 01, 2022. The current certification is valid through December 31, 2027.

How is this Mckesson Medical-surgical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68599474407. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68599-4744-7
11-Digit CMS (5-4-2)
68599-4744-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.